The US Food and Drug Administration (FDA) has approved a new version of an Alzheimer’s disease drug that can be given as a quick at-home weekly injection, offering patients a far more convenient option than lengthy infusion-center visits. It will be widely available from October 6, 2025. Continue Reading Category:Alzheimer's & Dementia, Brain Health, Body and Mind Tags:Biogen, Alzheimer's disease, Dementia, Drug development, Treatment, FDA, Cognitive functioning
